I agree. These guys can bring it down for half the price of covering up. Having trouble believing that they want this to go to seven so they can double their short position to break even. Would you really want to be sitting there after IBS data release with 16 million short when a buyout may come any day and destroy you? Even with selling, trying to unload 16 million shares sounds daunting and phase three CIC would be months away. Which raises the question why have they waited so late to do this when they've had it at $3.85 a couple of times. It's one thing to be stuck holding 8 million short with a possible buyout coming, quite another to be holding 16 million under the same circumstances. I think they want out.
I'm not sure I understand how that can happen if their basis is around $4.70 on let's say 6 million shares. Also, then why fight so hard to bring it down to $3.83 and then spend more money keeping it at around $4.40 to cover a few hundred thousands shares. The theory makes sense, but when I plug in the numbers, I'm not so sure. Not fighting, but trying to make the math work. Thanks all.
Not respecting these guys is a mistake. I think they're doing a little covering as you say. Always good to see some shares covered. They're clearly still all over our trading. I can find only one weakness in what they have been doing, and that is cover. History shows they've struggled to cover. Because they have failed in this, I have decided to highlight their failure by ramming this fact home over and over. It's the only thing they never talk about, and when they do, they lie. Covering is their soft spot. They can bring it down, but struggle to cover. So when they try to change the subject, I like to bring it back to their inability to close their trade. It's ultimately what makes them failures. They know it too.
That once Google and MM start offering our mobile marketing data and services to their clients, and their clients like it, they won't be able to take it away without looking like they're going backwards. Correct me if I'm wrong but isn't all of our new business SaaS based? Isn't that our highest margin service, much more so than mobile advertising? But then again both partners will be taking their cut. Will be interesting to see what the real numbers are. Better to have five percent of a huge cash stream, than a hundred percent of a small one. Our platform is so effortlessly scalable. Good to see Ivan cashing in on this type of usage. We then take the cash from these endeavors and use it to expand our own client base to generate more cash without paying them. Wonder how they deal with an MM customer that wants to switch to HIPP? The more deals like this we make, the more we look like "the" place to go if you need integrated mobile marketing. I love that we are best in breed at something. Bodes very well for the future, and the patents, if nothing else, solidify the company image, and make us unique. Nice to be a little exited about the future of the company again. And I'm liking these partnering deals as a way to unleash the scalability of our platform without giving up our independence. Good job guys.
Mobile, good news. Thanks. They've been working on this deal for some time. Good to see they pulled it off. Sometimes I wonder where we would be now if we had focused on our core business a couple of years ago. Oh well, we're doing it now. Now we can all ponder what this actually means to the company's bottom line, like the G/M deal. Next year is getting interesting already.
Just can't figure out how to cover any of their shares. I do like this strategy of indecisive hand ringing though. Hope the volume on the run up happens late and hard so you guys have nowhere to hide. In the meantime, try not to gnaw off your paws to escape the trap. Be patient, some thoughtful longs will come and release you. Trust me!
Same old story. Always going to cover "later." My teenager promises the same thing,"I'll do it later," but things just don't get done. So now you can't cover tomorrow. When will you? Apparently never.
So the masters of the universe fail to cover again. What's new. I think they're trying to set the record for holding onto a short position. Think you guys will manage to cover before the company is sold? I doubt it.
Yeah! Definitely no covering going on. Well, maybe you guys can work up the courage to cover a few shares tomorrow. Must be frustrating having such a tiny landing strip.
Shorts trying to paint another weird chart today.
Thanks aany, just what I wanted to know. Sorry to call out to you personally, but thought that you would be one of the few who would know.
Ocean, my best guess is that the screen name "stiffedbysgyp" is simply a very strage personna created by a professional poster, maybe Ding or his group. I've seen this personna used on companies that are cash poor or about to do a raise to add some kind of anecdotal credibility to the fact the company is hurting and needs cash. There was no worked performed or bill unpaid. Clearly, his banter is intentionally silly bordering on funny. I think of the personna as our company mascot. What is more, I think he likes being our mascot. Usually this personna disappears after a cash raise. But he just likes it here. And we all know that mascots were born to be kicked and ridiculed, so please have as much fun as you like with him ocean. Stiffed, you material is dated. Any job worth doing is worth doing well. Put some effort into the character would you. He could be much more funny, and creative in his snide remarks. He might also be a good friend of the President's, for example and be privy to his most initiate conversations. He could overhear Obama' conversations regarding SGYP. He could have a personal connection with God. All I'm asking is that you try, stiffed.
What's with that? Why no covering?
Wow. Broomcorn, you started a new identity just to respond to me? I'm flattered. Keep working it, we all have jobs, some better than others.
Some better-ranked med-drug stocks include WuXi PharmaTech (Cayman) Inc. (WX) and Jazz Pharmaceuticals Public Limited Company (JAZZ) with a Zacks Rank #1 (Strong Buy). Synergy Pharmaceuticals, Inc. (SGYP) with a Zacks Rank #2 (Buy) is also worth considering.